Jason Ryan

Chief Financial Officer

Mr. Ryan joined Foundation Medicine in May 2011 and brings over 12 years of financial and operations experience in emerging life science companies. Prior to joining Foundation Medicine, Mr. Ryan led the finance and strategic planning functions of Taligen Therapeutics (acquired by Alexion Pharmaceuticals), Codon Devices, and Genomics Collaborative (acquired by SeraCare Life Sciences). He began his career at Deloitte & Touche.

Mr. Ryan holds a BS in economics from Bates College and an MBA from Babson College, and earned his CPA in Massachusetts.